Healthcare Providers and Services
Company Overview of Genelex Corporation
Genelex Corporation operates as a DNA testing laboratory. It provides a program for personalized medication management consisting of DNA sensitivity testing, as well as GeneMedRx software, a software tool that predicts potential drug-drug and drug-gene interaction risk based on cytochrome P450 metabolism and genetic testing for interpreting the test results based on all of the medicines a patient is taking. The company offers services, such as parentage and forensic DNA testing, pharmacogenetic testing, ancestry DNA testing, clinical trial genotyping services, and predicitive genetic testing. Genelex Corporation, through its online store, also offers various at-home or legally admissible DNA...
3000 First Avenue
Seattle, WA 98121
Founded in 1987
Key Executives for Genelex Corporation
Co-Founder, Chief Executive Officer, Lab Director and Director
Co-Founder, Executive Vice President of Business Development and Director
Associate Laboratory Director
Compensation as of Fiscal Year 2016.
Genelex Corporation Key Developments
United States Department of Veterans Affairs Awards Federal Supply Schedule Contract to Genelex
Mar 15 16
Genelex announced the U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule (FSS V797D-50565) contract as a government supplier, which will take effect March 15, 2016. The contract makes pharmacogenetic testing accessible to clinicians in the Veteran’s Administration so their patients can immediately benefit from precision medicine. The YouScript Precision Prescribing System, developed by Genelex, helps eliminate adverse drug events caused by the cumulative impact of multiple medications and genetic variations missed by current drug interaction systems. Genelex uses a simple cheek swab to detect these variations, and then staff pharmacists provide personalized prescribing suggestions using the YouScript software which includes over 14,000 curated references on drug and gene interactions and how medications are metabolized in a patient’s body. The results not only reveal drug-gene interactions, but interactions between genes and multiple drugs to help providers find the best treatment for patients. After testing, providers can access YouScript in a secure, web-based portal to 'audition' new drugs in a clinical decision support tool rather than in a patient’s body. The software is also able to integrate directly into EHRs and other healthcare software systems. The approval will also allow healthcare providers in the Department of Defense, Bureau of Indian Affairs, and the Federal Bureau of Prisons to have access to this technology to reduce healthcare costs and improve patient care.
Genelex Announces Integration with Epic
Feb 23 16
Genelex announced enhanced connection with Epic. This new connectivity enables Genelex customers using Epic to better identify patients who are at the highest risk of adverse drug events based on drug-gene and drug-drug gene interactions which has been proven to significantly lower ED visits and hospitalizations. YouScript helps customers identify which patients are at the highest risk of adverse drug events, which ones would benefit from pharmacogenomic testing and what clinicians can do to optimize the safety and effectiveness of medications. Based on over 14,000 curated references and product inserts, YouScript determines the cumulative impact of genetics, medications, over-the-counters, herbals, and other factors offering ranked alternatives when interaction risk is found.
Genelex Names Kristine Ashcraft as CEO
Nov 23 15
Genelex announced the appointment of Kristine Ashcraft as its Chief Executive Officer. A member of the Genelex team since 2000, Kristine has been essential to the growth and development of the company. Having previously served as the Director of Sales/Marketing and, most recently, Chief Operating Officer, she brings undeniable enthusiasm and energy to her job while continuously working to accomplish the company mission, 'Science that benefits humanity'.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|